scPharmaceuticals (STU:2SX) Beginning Cash Position : €43.07 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is scPharmaceuticals Beginning Cash Position?

scPharmaceuticals's Beginning Cash Position for the quarter that ended in Mar. 2024 was €43.07 Mil.

scPharmaceuticals's quarterly Beginning Cash Position declined from Sep. 2023 (€66.86 Mil) to Dec. 2023 (€32.13 Mil) but then increased from Dec. 2023 (€32.13 Mil) to Mar. 2024 (€43.07 Mil).

scPharmaceuticals's annual Beginning Cash Position increased from Dec. 2021 (€63.72 Mil) to Dec. 2022 (€70.28 Mil) but then declined from Dec. 2022 (€70.28 Mil) to Dec. 2023 (€65.33 Mil).

scPharmaceuticals Beginning Cash Position Historical Data

The historical data trend for scPharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

scPharmaceuticals Beginning Cash Position Chart

scPharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

80.69

59.85

63.72

70.28

65.33

scPharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															66.54	69.64	66.86	32.13	43.07

scPharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

scPharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of scPharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

scPharmaceuticals (STU:2SX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » scPharmaceuticals Inc (STU:2SX) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

SCPH:USA

Address

2400 District Avenue, Suite 310, Burlington, MA, USA, 01803

Website

https://www.scpharmaceuticals.com

scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

scPharmaceuticals (STU:2SX) Headlines

No Headlines